Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Challenge of implants
- Determining biofilm and bone formation
- Rationale: personalized medicine
- Closed‐loop sensing and drug releasing device
- Sensors and biomedical telemetry
- Basic components of the system
- Part I
- Sensing bone growth with MWCNT‐Ti electrodes
- Anodized titanium
- Chemical vapor deposition
- SEMs of CNTs Grown-out of anodized titanium
- MWCNTs Grown Out of Anodized Titanium
- SEM of osteoblast adhesion after 4 hours (1)
- SEM of osteoblast adhesion after 4 hours (2)
- Osteoblast differentiation
- Sensing Fe(II/III) redox-cyclic voltammetry (1)
- Sensing Fe(II/III) redox-cyclic voltammetry (2)
- MWCNT‐Ti vs. GCE & PTE
- Extracellular components secreted by osteoblasts
- Sensing bone growth-cyclic voltammetry
- Sensing bone growth using MWCNT-Ti (1)
- Sensing bone growth using MWCNT-Ti (2)
- Identify sensing component in bone by SDS-PAGE
- Osteoid matrix protein
- The bone remodeling cycle
- Summary of part I
- Part II
- Drug release system
- Mechanism of embedding drugs in PPy films
- Osteoblast and fibroblast proliferation
- Staphylococcus Epidermidis adhesion for 1 hour
- Penicillin/streptomycin and dexamethasone release
- Macrophage adhesion in response stimulation
- Summary of part II
- Closed‐loop sensing and drug administration
- Summary and future directions
- Acknowledgements
Topics Covered
- Challenge of orthopedic implants
- Rationale behind personalized medicine
- Basic components of a closed-loop sensing and drug administration device
- Development of in situ orthopedic sensor
- Development of a voltage-controlled drug delivery coating
- Future directions
Talk Citation
Sirivisoot, S. (2015, May 4). Implantable nano sensors [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/IOGQ2762.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Sirinrath Sirivisoot has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Nanomedicine
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Sirinrath Sirivisoot.
I am actually a lecturer
of biological engineering,
and faculty of engineering at King
Mongkut University of Technology
in Thonburi in Bangkok, Thailand.
This talk is one of the contributions in
Nanometers in Theory, entitled
Implantable Nanosensors.
0:20
This talk will follow as
shown in this outline.
First I will talk about a
challenge of orthopedic implants,
the future of personalized
medicine for medical devices,
and the current supporting
technologies from nanoscience
and nanotechnology.
Then I will introduce our
idea of the closed-loop sensing
and drug release using medical device,
and how we develop an in
situ orthopedic sensor,
and voltage controlled
drug delivery coding.
And finally I will end with
conclusions and future directions.
0:54
The lifetime of orthopedic
implants is about 10 to 20 years.
Some device is failing at high
rates within a few years instead
of lasting 10 years or more.
The main reasons of
the implant failure
could be from
infection, inflammation,
causing swelling and pain,
osteolysis,
active bone resorption, involving wear particles,
worn from the contact surface.
Osteomyelitis, inflammation that is caused
by infection or implant loosening
form fibroblast tissue formation.
When a patient needs to a undergo
revision surgery some of the bills
were about US $400,000 in charges
related to hospitalization,
and an added US $28,000 in doctors bills.
Today human lifespan also
increased all around the world,
therefore there is still a
high need for better bone
growing material in the market.